Technology Solutions

Clinical Ink announces CentrosHealth Platform captures medical device data

Friday, July 24, 2015

Clinical Ink, a Winston-Salem, N.C.-based provider of eSource solutions for clinical trials, has updated CentrosHealth, a mobile patient engagement platform, to include streamlined connectivity for a wide range of medical devices. Medical device connectivity is powered by the 2net Mobile Platform from Qualcomm Life, a wholly owned subsidiary of Qualcomm Inc. This new platform was developed with cooperation from Novartis and PPD, which also are supporting a pilot clinical study before broad commercial use.

[Read More]

Parexel updates Perceptive MyTrials Platform

Friday, July 24, 2015

Global CRO Parexel International launched the next generation of its Perceptive MyTrials platform with advanced analytics capabilities. With the Perceptive MyTrials Analytics solution, clinical trial sponsors now can use a mobile-enabled, single entry-point to access predictive data analytics for multiple studies simultaneously. The solution offers real-time and aggregated analytics allowing sponsors and Parexel clinical research professionals to detect key signals and trends. The Perceptive MyTrials Analytics solution also offers cross-sponsor viewing options for clients who need to evaluate data from multiple sponsors.

[Read More]

Thermo Fisher Scientific, CDC partner to accelerate global microbial identification

Friday, July 17, 2015

Through a partnership with the Special Bacteriology Reference Laboratory at the Centers for Disease Control and Prevention (CDC), Thermo Fisher Scientific has developed an advanced software solution that enables global public health laboratories to directly access the CDC’s MicrobeNet online virtual reference lab database. Now, researchers can more quickly identify microbial pathogens potentially at the root of global outbreaks without needing to refer to multiple databases by instead utilizing one curated by subject matter experts in the field.

[Read More]

Illumina launches Illumina SeqLab

Friday, July 17, 2015

Illumina, a San Diego-based provider of sequencing and array-based technologies, has launched Illumina SeqLab, an integrated solution for customers with HiSeq X Systems to enable large-scale human whole-genome sequencing operations. Designed to increase laboratory efficiency for population-scale, human whole-genome sequencing (HWGS), this new offering provides a complete solution for Illumina customers who need streamlined workflows with integrated sample tracking and fast and accurate analysis solutions.

[Read More]

ActiGraph launches CenterPoint cloud-based study management software platform

Wednesday, July 8, 2015

ActiGraph, a provider of objective physical activity and sleep/wake measurement solutions for the global scientific community, has launched the CenterPoint Study Admin system, an innovative new software platform that leverages cloud and mobile technologies to transform the way real-world actigraphy data are collected and managed in pharmaceutical, clinical and academic research settings.

[Read More]

Google to test health-tracking wristband to collect clinical trial data

Monday, July 6, 2015

Google’s quest to expand its positioning of smart wearable devices beyond a contact lens for glucose monitoring has led the company to develop a new health-tracking wristband that can monitor pulse, heart rhythm, skin temperature, light exposure and noise levels for use in clinical trials and provide physicians with real-time data about their patients’ activity and vital signs between checkups.

[Read More]

Bracket acquires Clintara

Monday, June 29, 2015

Bracket Global, a provider of clinical research solutions, and Clintara, a privately held clinical service and technology company headquartered in Boston, Mass., have agreed to combine. Bracket will integrate the Clintara platform of surveillance strategies developed for clinical trials within Bracket’s proprietary electronic platform for Clinical Outcome Assessments (eCOA). The integration will include Clintara’s innovative C-VISA Subject Eligibility Validation program designed to ensure appropriate patients are enrolled in clinical trials.

[Read More]